Results 271 to 280 of about 419,255 (384)

HDL Nanodiscs Loaded with Liver X Receptor Agonist Decreases Tumor Burden and Mediates Long‐term Survival in Mouse Glioma Model

open access: yesSmall, Volume 21, Issue 20, May 19, 2025.
Synthetic high‐density lipoprotein (sHDL) nanodiscs are developed to co‐deliver liver‐X‐Receptor (LXR) agonists and Toll‐like receptor 9 (TLR‐9) agonist CpG for glioma treatment. By upregulation of ATP‐binding cassette transporter A1 (ABCA1), LXR agonists synergize with sHDL nanodiscs to deplete cholesterol and induce apoptosis of glioma cells.
Troy A. Halseth   +12 more
wiley   +1 more source

Successful Treatment With Intravenous Lipid Emulsion of Accidental Amantadine Overdose: A Case Report

open access: yesVeterinary Medicine and Science, Volume 11, Issue 3, May 2025.
Intravenous lipid emulsion therapy may be an appropriate treatment for amantadine toxicity. While amantadine levels were not performed, clinical signs improved following intravenous lipid emulsions. Additional studies recommend evaluating direct changes to amantadine levels with this therapy in the future.
Brett Hogberg   +2 more
wiley   +1 more source

Photobiomodulation as part of multimodal analgesia to improve pain relief and wound healing after elective caesarean section: A protocol for randomized controlled trial. [PDF]

open access: yesPLoS One
Khaled M   +17 more
europepmc   +1 more source

Continuous deep sedation versus minimal sedation after cardiac arrest and resuscitation (SED‐CARE): A protocol for a randomized clinical trial

open access: yesActa Anaesthesiologica Scandinavica, Volume 69, Issue 5, May 2025.
Abstract Background Sedation is often provided to resuscitated out‐of‐hospital cardiac arrest (OHCA) patients to tolerate post‐cardiac arrest care, including temperature management. However, the evidence of benefit or harm from routinely administered deep sedation after cardiac arrest is limited.
A. Ceric   +77 more
wiley   +1 more source

Home - About - Disclaimer - Privacy